{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:19:21Z","timestamp":1790083161651,"version":"4.0.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","funder":[{"name":"Joint Program Committee-7\/Radiation Health Effects Research Program","award":["DM178016"],"award-info":[{"award-number":["DM178016"]}]},{"DOI":"10.13039\/100007188","name":"Uniformed Services University of the Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012414","name":"Armed Forces Radiobiology Research Institute","doi-asserted-by":"publisher","award":["# 12080"],"award-info":[{"award-number":["# 12080"]}],"id":[{"id":"10.13039\/100012414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Exposure to ionizing radiation results in various subsyndromes of acute radiation syndrome, including the hematopoietic subsyndrome. Currently, there are no Food and Drug Administration approved drugs to protect from ionizing radiation exposure when administered prophylactically. Genistein, a soy isoflavone, has been implicated as a potent radioprotector. However, because of its poor bioavailability, it has not been developed into a medical countermeasure. To overcome this, an aqueous nanosuspension of synthetic genistein nanoparticles (BIO 300) has been developed. This study investigated the radioprotective efficacy of BIO 300 Injectable Suspension (BIO 300 IS) in a nonhuman primate (NHP) model of total-body irradiation (TBI).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>Eight rhesus macaques aged 8-14 years and weighing 10.75-25.1 kg were utilized in this study. Four were dosed intramuscularly (im) with BIO 300 IS (50 mg\/kg) and 4 were dosed im with vehicle 24 hours before exposure to 5.8 Gy total-body radiation. Animals were monitored for survival and clinical observations for 60 days post-TBI. All animals underwent necropsy following euthanasia and tissues were collected for histopathology. Whole blood and serum were collected to analyze complete blood counts and blood biochemistry, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 4 animals treated with BIO 300 IS, 3 survived through the 60-day study whereas only 2 of the 4 animals treated with vehicle survived. BIO 300 IS-treated animals had higher nadirs and\/or faster recovery post-nadir for neutrophils, platelets, red blood cells, hemoglobin, and hematocrit. No difference in white blood cell counts were observed between BIO 300 IS- and vehicle-treated animals. Histopathological analysis revealed that BIO 300 IS-treated animals exhibited less hemorrhage, bone marrow atrophy, and gut associated lymphoid tissue depletion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The data presented here suggest that BIO 300 IS radioprotective efficacy is mediated by improving red blood cell and platelet counts while also reducing adverse histopathological findings in NHPs undergoing TBI. These results suggest a potential novel mechanism of action for BIO 300 involving the protection of the megakaryocyte\u2014erythropoietic progenitor population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/milmed\/usaf325","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T07:36:37Z","timestamp":1749540997000},"page":"746-754","source":"Crossref","is-referenced-by-count":4,"title":["Prophylactic Administration of BIO 300, A Radiation Medical Countermeasure, Improves Erythrocyte-Associated Parameters in the Rhesus Macaque Model"],"prefix":"10.1093","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7942-2497","authenticated-orcid":false,"given":"Oluseyi O","family":"Fatanmi","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Molecular Therapeutics, F. Edward H\u00e9bert School of Medicine, Uniformed Services University of the Health Sciences , Bethesda, MD 20814,","place":["United States"]},{"name":"Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences , Bethesda, MD 20814,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7613-7455","authenticated-orcid":false,"given":"Stephen Y","family":"Wise","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Molecular Therapeutics, F. Edward H\u00e9bert School of Medicine, Uniformed Services University of the Health Sciences , Bethesda, MD 20814,","place":["United States"]},{"name":"Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences , Bethesda, MD 20814,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2645-7570","authenticated-orcid":false,"given":"Sarah A","family":"Petrus","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Molecular Therapeutics, F. Edward H\u00e9bert School of Medicine, Uniformed Services University of the Health Sciences , Bethesda, MD 20814,","place":["United States"]},{"name":"Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences , Bethesda, MD 20814,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4149-6614","authenticated-orcid":false,"given":"Issa","family":"Melendez-Miranda","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Molecular Therapeutics, F. Edward H\u00e9bert School of Medicine, Uniformed Services University of the Health Sciences , Bethesda, MD 20814,","place":["United States"]},{"name":"Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences , Bethesda, MD 20814,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2108-2274","authenticated-orcid":false,"given":"Alana D","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Molecular Therapeutics, F. Edward H\u00e9bert School of Medicine, Uniformed Services University of the Health Sciences , Bethesda, MD 20814,","place":["United States"]},{"name":"Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences , Bethesda, MD 20814,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3672-9210","authenticated-orcid":false,"given":"Hannah M","family":"Olson","sequence":"additional","affiliation":[{"name":"Humanetics Corporation , Minneapolis, MN 55331,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2683-4383","authenticated-orcid":false,"given":"Artur A","family":"Serebrenik","sequence":"additional","affiliation":[{"name":"Humanetics Corporation , Minneapolis, MN 55331,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A","family":"Lugo-Roman","sequence":"additional","affiliation":[{"name":"Department of Laboratory Animal Resources, Uniformed Services University of the Health Sciences , Bethesda, MD 20814,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6643-6259","authenticated-orcid":false,"given":"Michael D","family":"Kaytor","sequence":"additional","affiliation":[{"name":"Humanetics Corporation , Minneapolis, MN 55331,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6631-3849","authenticated-orcid":false,"given":"Vijay K","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Molecular Therapeutics, F. Edward H\u00e9bert School of Medicine, Uniformed Services University of the Health Sciences , Bethesda, MD 20814,","place":["United States"]},{"name":"Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences , Bethesda, MD 20814,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"issue":"Supplement_27","key":"2025091919355013300_usaf325-B1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1259\/bjr\/70312032","article-title":"The pathology of multi-organ involvement: two autopsy cases from the Tokai-Mura criticality accident","author":"Uozaki","year":"2005","journal-title":"BJR"},{"key":"2025091919355013300_usaf325-B2","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/01.HP.0000278843.27969.74","article-title":"Health effects in those with acute radiation sickness from the Chernobyl accident","volume":"93","author":"Mettler","year":"2007","journal-title":"Health Phys"},{"issue":"Suppl 1","key":"2025091919355013300_usaf325-B3","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1001\/dmp.2011.17","article-title":"Radiation injury after a nuclear detonation: medical consequences and the need for scarce resources allocation","volume":"5","author":"DiCarlo","year":"2011","journal-title":"Disaster Med Public Health Prep"},{"key":"2025091919355013300_usaf325-B4","author":"US Food and Drug Administration","year":"2024"},{"key":"2025091919355013300_usaf325-B5","author":"US Food and Drug Administration"},{"key":"2025091919355013300_usaf325-B6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/13543784.2020.1757648","article-title":"BIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure","volume":"29","author":"Singh","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"2025091919355013300_usaf325-B7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/jrr\/rrz014","article-title":"Mechanism and therapeutic window of a genistein nanosuspension to protect against \u00adhematopoietic-acute radiation syndrome","volume":"60","author":"Landauer","year":"2019","journal-title":"J Radiat Res"},{"key":"2025091919355013300_usaf325-B8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1667\/RADE-22-00142.1","article-title":"The radioprotectant, BIO 300, protects the lungs from total-body irradiation injury in C57L\/J Mice","volume":"199","author":"Singh","year":"2023","journal-title":"Radiat Res"},{"key":"2025091919355013300_usaf325-B9","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/milmed\/usae156","article-title":"BIO 300: a prophylactic radiation countermeasure for acute radiation syndrome","volume":"189","author":"Singh","year":"2024","journal-title":"Mil Med"},{"key":"2025091919355013300_usaf325-B10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/cpdd.1188","article-title":"Safety, pharmacokinetics, and biomarkers of an amorphous solid dispersion of genistein, a radioprotectant, in healthy volunteers","volume":"12","author":"Serebrenik","year":"2023","journal-title":"Clin Pharmacol Drug Dev"},{"key":"2025091919355013300_usaf325-B11","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals","year":"2011","edition":"8th ed"},{"key":"2025091919355013300_usaf325-B12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051231","article-title":"Pharmacokinetic and metabolomic studies with BIO 300, a nanosuspension of genistein, in a nonhuman primate model","volume":"20","author":"Cheema","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025091919355013300_usaf325-B13","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1080\/09553002.2021.1981556","article-title":"A novel oral formulation of BIO 300 confers prophylactic radioprotection from acute radiation syndrome in mice","volume":"98","author":"Singh","year":"2022","journal-title":"Int J Radiat Biol"},{"key":"2025091919355013300_usaf325-B14","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.1038\/s41598-021-85669-6","article-title":"Transcriptome of rhesus macaque (Macaca mulatta) exposed to total-body irradiation","volume":"11","author":"Li","year":"2021","journal-title":"Sci Rep"},{"key":"2025091919355013300_usaf325-B15","doi-asserted-by":"publisher","first-page":"11449","DOI":"10.1038\/s41598-021-91067-9","article-title":"Analysis of the metabolomic profile in serum of irradiated nonhuman primates treated with Ex-Rad, a radiation countermeasure","volume":"11","author":"Li","year":"2021","journal-title":"Sci Rep"},{"key":"2025091919355013300_usaf325-B16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1667\/RADE-22-00101.1","article-title":"Determination of lethality curve for cobalt-60 gamma-radiation source in rhesus macaques using subject-based supportive care","volume":"198","author":"Singh","year":"2022","journal-title":"Radiat Res"},{"key":"2025091919355013300_usaf325-B17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1667\/RR14127.1","article-title":"Radioprotective efficacy of gamma-tocotrienol in nonhuman primates","volume":"185","author":"Singh","year":"2016","journal-title":"Radiat Res"},{"key":"2025091919355013300_usaf325-B18","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1667\/RADE-24-00036.1","article-title":"An overview of radiation countermeasure development in radiation research from 1954 to 2024","volume":"202","author":"Kiang","year":"2024","journal-title":"Radiat Res"},{"key":"2025091919355013300_usaf325-B19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/17460441.2017.1323863","article-title":"Nonhuman primates as models for the discovery and development of radiation countermeasures","volume":"12","author":"Singh","year":"2017","journal-title":"Expert Opin Drug Dis"},{"key":"2025091919355013300_usaf325-B20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/HP.0000000000000878","article-title":"Efficacy of neulasta or neupogen on H-ARS and GI-ARS mortality and hematopoietic recovery in nonhuman primates after 10-Gy irradiation with 2.5% bone marrow \u00adsparing","volume":"116","author":"Farese","year":"2019","journal-title":"Health Phys"},{"key":"2025091919355013300_usaf325-B21","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1358\/dot.2015.51.9.2386730","article-title":"Filgrastim for the treatment of hematopoietic acute radiation syndrome","volume":"51","author":"Farese","year":"2015","journal-title":"Drugs Today"},{"key":"2025091919355013300_usaf325-B22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1667\/RR2900.1","article-title":"Pegfilgrastim administered in an abbreviated schedule, significantly improved neutrophil recovery after high-dose radiation-induced myelosuppression in rhesus macaques","volume":"178","author":"Farese","year":"2012","journal-title":"Radiat Res"},{"key":"2025091919355013300_usaf325-B23","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.ijrobp.2018.11.043","article-title":"Neulasta regimen for the hematopoietic acute radiation syndrome: effects beyond neutrophil recovery","volume":"103","author":"Legesse","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025091919355013300_usaf325-B24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1667\/RR13940.1","article-title":"Pegfilgrastim improves survival of lethally irradiated nonhuman primates","volume":"183","author":"Hankey","year":"2015","journal-title":"Radiat Res"},{"key":"2025091919355013300_usaf325-B25","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1080\/14712598.2022.2143261","article-title":"Sargramostim in acute radiation syndrome","volume":"22","author":"Lazarus","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"2025091919355013300_usaf325-B26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1667\/RADE-20-00131.1","article-title":"Sargramostim (rhu GM-CSF) improves survival of non-human primates with severe bone marrow suppression after acute, high-dose, whole-body irradiation","volume":"195","author":"Clayton","year":"2021","journal-title":"Radiat Res"},{"key":"2025091919355013300_usaf325-B27","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1080\/09553002.2019.1673499","article-title":"Efficacy of delayed administration of sargramostim up to 120 hours post exposure in a nonhuman primate total body radiation model","volume":"97","author":"Zhong","year":"2021","journal-title":"Int J Radiat Biol"},{"key":"2025091919355013300_usaf325-B28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1358\/dot.2018.54.11.2899370","article-title":"An update on sargramostim for treatment of acute radiation syndrome","volume":"54","author":"Singh","year":"2018","journal-title":"Drugs Today"},{"key":"2025091919355013300_usaf325-B29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ijrobp.2023.05.008","article-title":"Survival and hematologic benefits of romiplostim after acute radiation exposure supported FDA approval under the animal rule","volume":"117","author":"Bunin","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025091919355013300_usaf325-B30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/09553002.2019.1605465","article-title":"\u00adRomiplostim (Nplate((R))) as an effective radiation countermeasure to improve survival and platelet recovery in mice","volume":"96","author":"Bunin","year":"2020","journal-title":"Int J Radiat Biol"},{"key":"2025091919355013300_usaf325-B31","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1080\/09553000802317778","article-title":"Genistein induces radioprotection by hematopoietic stem cell quiescence","volume":"84","author":"Davis","year":"2008","journal-title":"Int J Radiat Biol"},{"key":"2025091919355013300_usaf325-B32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1667\/rr3326.1","article-title":"Genistein nanoparticles protect mouse hematopoietic system and prevent proinflammatory factors after gamma irradiation","volume":"180","author":"Ha","year":"2013","journal-title":"Radiat Res"},{"key":"2025091919355013300_usaf325-B33","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1667\/RR15440.1","article-title":"Mitigating effects of 1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) on hematopoietic acute radiation syndrome after total-body ionizing irradiation in mice","volume":"192","author":"Kim","year":"2019","journal-title":"Radiat Res"},{"key":"2025091919355013300_usaf325-B34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.exger.2016.12.005","article-title":"An overview of nonhuman primates in aging research","volume":"94","author":"Mattison","year":"2017","journal-title":"Exp Gerontol"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/190\/Supplement_2\/746\/64288036\/usaf325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/190\/Supplement_2\/746\/64288036\/usaf325.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T23:35:57Z","timestamp":1758324957000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/190\/Supplement_2\/746\/8256279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":34,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2025,9,16]]},"published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usaf325","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,9,1]]}}}